Emergent Biosolutions (EBS) Issues Q3 Miss
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.05 -1.59%
EPS Growth %: -31.3%
Financial Fact:
Weighted-average number of shares - basic: 40.47M
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: -31.3%
Financial Fact:
Weighted-average number of shares - basic: 40.47M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Emergent Biosolutions (NYSE: EBS) reported Q3 EPS of $0.04, $0.06 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $58.8 million versus the consensus estimate of $63.59 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Samsung 2q Oper Profit 89.40t Won, Est. 84.2t Won
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
